MRRFX | VMVIX | MRRFX / VMVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 22 years | 18 years | - |
Gain YTD | 6.616 | 14.287 | 46% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 3000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.07B | 30.5B | 4% |
Annual Yield % from dividends | 1.61 | 2.03 | 79% |
Returns for 1 year | 11.48 | 21.83 | 53% |
Returns for 3 years | 3.29 | 17.59 | 19% |
Returns for 5 years | 27.80 | 47.93 | 58% |
Returns for 10 years | -10.57 | 96.48 | -11% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QSPT | 26.55 | 0.01 | +0.04% |
FT Cboe Vest Nasdaq-100® Buffer ETF Sep | |||
FTA | 78.40 | -0.08 | -0.11% |
First Trust Large Cap Val AlphaDEX® ETF | |||
LFEQ | 47.52 | -0.06 | -0.14% |
VanEck Lg/Flat Trend ETF | |||
IEFA | 75.96 | -0.21 | -0.28% |
iShares Core MSCI EAFE ETF | |||
BIB | 66.68 | -0.58 | -0.86% |
ProShares Ultra Nasdaq Biotechnology |